Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity

Neuron

Volumn 37, Issue 5, 2003, Pages 735-749

  Staropoli, John F ^a   McDermott, Caroline ^a   Martinat, Cécile ^a   Schulman, Brenda ^b   Demireva, Elena ^a   Abeliovich, Asa ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN 1; CYCLIN E; KAINIC ACID; PARKIN; PROTEIN; PROTEIN F BOX; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAIN NERVE CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCEPHALON; MITOSIS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 0037422010     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00084-9     Document Type: Article

References (60)

1. Alves-Rodrigues A., Gregori L., Figueiredo-Pereira M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21:1998;516-520.
2. Burke R.E., Kholodilov N.G. Programmed cell death. does it play a role in Parkinson's disease? Ann. Neurol. 44:1998;S126-S133.
3. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1:1999;193-199.
4. Chung K.K., Dawson V.L., Dawson T.M. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. 24:2001;S7-S14. a.
5. Chung K.K., Zhang Y., Lim K.L., Tanaka Y., Huang H., Gao J., Ross C.A., Dawson V.L., Dawson T.M. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1. implications for Lewy-body formation in Parkinson disease Nat. Med. 7:2001;1144-1150. b.
6. Clurman B.E., Sheaff R.J., Thress K., Groudine M., Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990.
7. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., Memo M. Activation of cell-cycle-associated proteins in neuronal death. a mandatory or dispensable path? Trends Neurosci. 24:2001;25-31.
8. Dealy M.J., Nguyen K.V., Lo J., Gstaiger M., Krek W., Elson D., Arbeit J., Kipreos E.T., Johnson R.S. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet. 23:1999;245-248.
9. Dong X., Tsuda L., Zavitz K.H., Lin M., Li S., Carthew R.W., Zipursky S.L. ebi regulates epidermal growth factor receptor signaling pathways in Drosophila. Genes Dev. 13:1999;954-965.
10. Ekholm S.V., Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12:2000;676-684.
11. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
12. Ericson J., Morton S., Kawakami A., Roelink H., Jessell T.M. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell. 87:1996;661-673.
13. Fallon L., Moreau F., Croft B.G., Labib N., Gu W.J., Fon E.A. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 25:2001;25.
14. Hershko A., Heller H., Elias S., Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J. Biol. Chem. 258:1983;8206-8214.
15. Husseman J.W., Nochlin D., Vincent I. Mitotic activation. a convergent mechanism for a cohort of neurodegenerative diseases Neurobiol. Aging. 21:2000;815-828.
16. Hynes M., Porter J.A., Chiang C., Chang D., Tessier-Lavigne M., Beachy P.A., Rosenthal A. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron. 15:1995;35-44.
17. Imai Y., Soda M., Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 46:2000;35661-35664.
18. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell. 105:2001;891-902.
19. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., Takahashi R. CHIP is associated with Parkin, a gene responsible for familial parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell. 10:2002;55-67.
20. Joazeiro C.A., Weissman A.M. RING finger proteins. mediators of ubiquitin ligase activity Cell. 102:2000;549-552.
21. Kamura T., Koepp D.M., Conrad M.N., Skowyra D., Moreland R.J., Iliopoulos O., Lane W.S., Kaelin W.G. Jr., Elledge S.J., Conaway R.C.et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science. 284:1999;657-661.
22. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
23. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 419:2002;367-374.
24. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 294:2001;173-177.
25. Krichevsky A.M., Kosik K.S. RNAi functions in cultured mammalian neurons. Proc. Natl. Acad. Sci. USA. 99:2002;11926-11929.
26. Kubo S.I., Kitami T., Noda S., Shimura H., Uchiyama Y., Asakawa S., Minoshima S., Shimizu N., Mizuno Y., Hattori N. Parkin is associated with cellular vesicles. J. Neurochem. 78:2001;42-54.
27. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339:1998;1044-1053.
28. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T.et al. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
29. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305:2001;217-228.
30. Lotharius J., Dugan L.L., O'Malley K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19:1999;1284-1293.
31. Matsuzawa S.I., Reed J.C. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell. 7:2001;915-926.
32. Moberg K.H., Bell D.W., Wahrer D.C., Haber D.A., Hariharan I.K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 413:2001;311-316.
33. Neystat M., Rzhetskaya M., Oo T.F., Kholodilov N., Yarygina O., Wilson A., El-Khodor B.F., Burke R.E. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo. J. Neurochem. 77:2001;1611-1625.
34. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16:1996;436-447.
35. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22:1999;123-144.
36. Padmanabhan J., Park D.S., Greene L.A., Shelanski M.L. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J. Neurosci. 19:1999;8747-8756.
37. Park D.S., Morris E.J., Padmanabhan J., Shelanski M.L., Geller H.M., Greene L.A. Cyclin-dependent kinases participate in death of neurons evoked by DNA- damaging agents. J. Cell Biol. 143:1998;457-467.
38. Patton E.E., Willems A.R., Tyers M. Combinatorial control in ubiquitin-dependent proteolysis. don't Skp the F-box hypothesis Trends Genet. 14:1998;236-243.
39. Petrucelli L., O'Farrell C., Lockhart P.J., Baptista M., Kehoe K., Vink L., Choi P., Wolozin B., Farrer M., Hardy J.et al. Parkin protects against the toxicity associated with mutant alpha-synuclein. proteasome dysfunction selectively affects catecholaminergic neurons Neuron. 36:2002;1007-1019.
40. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R.et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
41. Raina A.K., Zhu X., Rottkamp C.A., Monteiro M., Takeda A., Smith M.A. Cyclin' toward dementia. cell cycle abnormalities and abortive oncogenesis in Alzheimer disease J. Neurosci. Res. 61:2000;128-133.
42. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell. 101:2000;657-669.
43. Schlossmacher M.G., Frosch M.P., Gai W.P., Medina M., Sharma N., Forno L., Ochiishi T., Shimura H., Sharon R., Hattori N.et al. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol. 160:2002;1655-1667.
44. Schulz J.B., Matthews R.T., Klockgether T., Dichgans J., Beal M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell. Biochem. 174:1997;193-197.
45. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K.et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:2000;302-305. a.
46. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K.et al. Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:2000;302-305. b.
47. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., Selkoe D.J. Ubiquitination of a new form of alpha-synuclein by parkin from human brain. implications for Parkinson's disease Science. 293:2001;263-269.
48. Singer J.D., Gurian-West M., Clurman B., Roberts J.M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13:1999;2375-2387.
49. Skowyra D., Craig K.L., Tyers M., Elledge S.J., Harper J.W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 91:1997;209-219.
50. Skowyra D., Koepp D.M., Kamura T., Conrad M.N., Conaway R.C., Conaway J.W., Elledge S.J., Harper J.W. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science. 284:1999;662-665.
51. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
52. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 413:2001;316-322.
53. Takada M., Matsumura M., Kojima J., Yamaji Y., Inase M., Tokuno H., Nambu A., Imai H. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation. Eur. J. Neurosci. 12:2000;1771-1780.
54. Troy C.M., Rabacchi S.A., Hohl J.B., Angelastro J.M., Greene L.A., Shelanski M.L. Death in the balance. alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation J. Neurosci. 21:2001;5007-5016.
55. Verdaguer E., Garcia-Jorda E., Canudas A.M., Dominguez E., Jimenez A., Pubill D., Escubedo E., Pallas J.C., Camins A. Kainic acid-induced apoptosis in cerebellar granule neurons. an attempt at cell cycle re-entry Neuroreport. 13:2002;413-416.
56. Winston J.T., Chu C., Harper J.W. Culprits in the degradation of cyclin E apprehended. Genes Dev. 13:1999;2751-2757.
57. Wu G., Hubbard E.J., Kitajewski J.K., Greenwald I. Evidence for functional and physical association between Caenorhabditis elegans SEL-10, a Cdc4p-related protein, and SEL-12 presenilin. Proc. Natl. Acad. Sci. USA. 95:1998;15787-15791.
58. Wu G., Lyapina S., Das I., Li J., Gurney M., Pauley A., Chui I., Deshaies R.J., Kitajewski J. SEL-10 is an inhibitor of Notch signaling that targets Notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 21:2001;7403-7415.
59. Zennou V., Serguera C., Sarkis C., Colin P., Perret E., Mallet J., Charneau P. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19:2001;446-450.
60. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., Dawson T.M. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA. 97:2000;13354-13359.